In thyroid carcinoma, Chen et al. demonstrated that elevated GPX4 expression correlated with advanced tumor invasion (T3–T4 stage) and metastatic progression (pathologic stages III–IV), establishing its independent prognostic value through multivariate Cox regression analysis [13]. Here, GPX4 is linked to thyroid gland carcinoma.